Robert White - Medtronic Plc President
| MDTC34 Stock | BRL 244.06 0.40 0.16% |
President
Mr. Robert J. White is Executive Vice President and President of Medtronics Minimally Invasive Therapies Group of the company. He joined Medtronic upon the close of the Covidien acquisition by Medtronic in 2015 as President for the APAC Region, based in Singapore. In this role, White was responsible for the commercial growth of Medtronics business in the region, including leadership for Medtronics four main product and therapy groups, regional business development efforts, government and partner development strategies, talent development and retention, and the operations of the companys enabling functions. since 2017.
| Age | 60 |
| Tenure | 7 years |
| Phone | 353 1 438 1700 |
| Web | https://www.medtronic.com |
Robert White Latest Insider Activity
Tracking and analyzing the buying and selling activities of Robert White against Medtronic Plc stock is an integral part of due diligence when investing in Medtronic Plc. Robert White insider activity provides valuable insight into whether Medtronic Plc is net buyers or sellers over its current business cycle. Note, Medtronic Plc insiders must abide by specific rules, including filing SEC forms every time they buy or sell Medtronic Plc'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Robert White over six months ago Disposition of 10000 shares by Robert White of AtriCure at 15.96 subject to Rule 16b-3 | ||
Robert White over a year ago Disposition of 12397 shares by Robert White of Medtronic PLC subject to Rule 16b-3 | ||
Robert White over a year ago Exercise or conversion by Robert White of 20000 shares of AtriCure subject to Rule 16b-3 |
Medtronic Plc Management Efficiency
The company has return on total asset (ROA) of 0.0422 % which means that it generated a profit of $0.0422 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0833 %, meaning that it generated $0.0833 on every $100 dollars invested by stockholders. Medtronic Plc's management efficiency ratios could be used to measure how well Medtronic Plc manages its routine affairs as well as how well it operates its assets and liabilities.Management Performance
| Return On Equity | 0.0833 | |||
| Return On Asset | 0.0422 |
Medtronic plc Leadership Team
Elected by the shareholders, the Medtronic Plc's board of directors comprises two types of representatives: Medtronic Plc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medtronic. The board's role is to monitor Medtronic Plc's management team and ensure that shareholders' interests are well served. Medtronic Plc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medtronic Plc's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sean Lennon, Chief Officer | ||
| Jennifer Kirk, Global Officer | ||
| Geoffrey Martha, Executive Vice President and President - Restorative Therapies Group | ||
| Robert White, Executive Vice President and President of Medtronic’s Minimally Invasive Therapies Group | ||
| Ryan Weispfenning, Vice President - Investor Relations | ||
| Robert Hoedt, Executive Vice President and President - EMEAC | ||
| Mark Ploof, Sr Services | ||
| Ivan Fong, Gen VP | ||
| MSc MD, Medical Scientific | ||
| Karen Parkhill, CFO, Executive Vice President |
Medtronic Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Medtronic Plc a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0833 | |||
| Return On Asset | 0.0422 | |||
| Profit Margin | 0.14 % | |||
| Operating Margin | 0.20 % | |||
| Current Valuation | 625.84 B | |||
| Shares Outstanding | 2.66 B | |||
| Price To Earning | 52.06 X | |||
| Price To Book | 2.03 X | |||
| Price To Sales | 18.03 X | |||
| Revenue | 31.69 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Medtronic Stock
When determining whether Medtronic plc is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Medtronic Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Medtronic Plc Stock. Highlighted below are key reports to facilitate an investment decision about Medtronic Plc Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medtronic plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Medtronic Stock refer to our How to Trade Medtronic Stock guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.